Research presents new hope of early diagnosis of major cause of blindness

January 22, 2014 by Marie Daniels
Research presents new hope of early diagnosis of major cause of blindness
Scan of a diabetic eye.

Research is under way to develop new techniques for detecting diabetic retinopathy at early onset with the hope of improving prevention and treatment of this major cause of blindness.

Diabetic retinopathy is a common complication of , occurring when levels damage the cells in the retina at the back of the eye.

The disease is the most common cause of sight loss in people of working age. It is estimated that in England every year 4,200 people are at risk of blindness caused by , with 1,280 new cases identified annually.

As part of the Retinal Vascular Modelling, Measurement and Diagnosis (REVAMMAD) project led by the University of Lincoln, UK, Marie Curie Researcher Georgios Leontidis is investigating new methods for the early screening and diagnosis of the disease by developing computer models which can detect small changes in the blood vessels of the eye.

Funded by the European Union's 7th Framework (FP7) Marie Curie Initial Training Network programme, the University of Lincoln has been awarded 900,000 euros from the 3.8 million euro budget to lead the project and to develop and measurement training and research.

It aims to improve diagnosis, prognosis and prevention of diseases such as diabetes, hypertension, stroke and and retinal diseases.

All people with diabetes are at some risk of developing diabetic retinopathy, regardless of whether their condition is controlled by diet, tablets or insulin.

Diabetic retinopathy progresses with time, but may not cause symptoms until it is advanced and close to affecting the retina. The retina is a light-sensitive layer of tissue, lining the inner surface of the eye. The optics of the eye create an image of the visual world on the retina in a similar way to the film in a camera.

Diabetes affects the structure of the , making them stiffer. At an advanced point this causes them to break, creating haemorrhages and micro aneurysms, which are the first stages of diabetic retinopathy.

Georgios, an Electronics and Computer Engineer within the University of Lincoln's School of Computer Science, is investigating the effects of diabetes on the retina's vessel walls and how this ultimately affects the flow of blood in the whole vasculature of the retina.

He said: "Here at the University of Lincoln, our efforts focus on analysing images of before the first stage of diabetic retinopathy. In that way we want to see what changes diabetes causes to the vessels and how these changes progress to retinopathy. We will then try to correlate the standard features we extract from these images with functional changes that occur, such as abnormality in blood pressure, blood flow volume and blood flow velocity, as well as to associate them with some risk factors like age, type of diabetes, duration of diabetes, gender and smoking."

Explore further: Two players produce destructive cascade of diabetic retinopathy

Related Stories

Two players produce destructive cascade of diabetic retinopathy

January 13, 2014
The retina can be bombarded by reactive oxygen species in diabetes, prompting events that destroy healthy blood vessels, form leaky new ones and ruin vision.

Study explains why diabetic retinopathy is difficult to treat

October 7, 2013
Damage to the retina due to diabetes can be ameliorated only partially, despite treatment with the standard drug metformin. Scientists of Helmholtz Zentrum München have discovered that metformin treatment normalizes the ...

Diabetes leading to blindness in many people

November 30, 2012
Diabetes is the leading cause of new cases of blindness among adults 20 to 74 years old. Dr. Michael Grodin, co-director of retinal services and director of clinical research at Katzen Eye Group, with locations around Baltimore, ...

New study aims to use stem cells to help save sight of diabetes sufferers

February 14, 2013
Scientists at Queen's University Belfast are hoping to develop a novel approach that could save the sight of millions of diabetes sufferers using adult stem cells.

Many people with diabetes still lose vision, despite availability of vision-sparing treatment

December 19, 2013
Despite recent advances in prevention and treatment of most vision loss attributed to diabetes, a new study shows that fewer than half of Americans with damage to their eyes from diabetes are aware of the link between the ...

Study finds novel therapy that may prevent damage to the retina in diabetic eye diseases

July 27, 2012
Researchers at the University of Michigan Kellogg Eye Center have identified a compound that could interrupt the chain of events that cause damage to the retina in diabetic retinopathy. The finding is significant because ...

Recommended for you

Genome editing with CRISPR-Cas9 prevents angiogenesis of the retina

July 24, 2017
A research team from the Schepens Eye Research Institute of Massachusetts Eye and Ear has successfully prevented mice from developing angiogenesis of the retina—the sensory tissue at the back of the eye—using gene-editing ...

Too little vitamin D may hinder recovery of injured corneas

July 24, 2017
Injury or disease in combination with too little vitamin D can be bad for the window to your eyes.

Combination of type 2 diabetes and sleep apnoea indicates eyesight loss within four years

July 4, 2017
Research led by the University of Birmingham has discovered that patients who suffer from both Type 2 diabetes and obstructive sleep apnoea are at greater risk of developing a condition that leads to blindness within an average ...

Nearly 60% of pinkeye patients receive antibiotic eye drops, but they're seldom necessary

June 28, 2017
A new study suggests that most people with acute conjunctivitis, or pinkeye, are getting the wrong treatment.

Magnetic implants used to treat 'dancing eyes'

June 26, 2017
A research team has successfully used magnets implanted behind a person's eyes to treat nystagmus, a condition characterised by involuntary eye movements.

Drug shows promise against vision-robbing disease in seniors

June 21, 2017
An experimental drug is showing promise against an untreatable eye disease that blinds older adults—and intriguingly, it seems to work in patients who carry a particular gene flaw that fuels the damage to their vision.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.